• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肺量测定法的应用:在初级保健环境中检测慢性阻塞性肺疾病。

Spirometry use: detection of chronic obstructive pulmonary disease in the primary care setting.

机构信息

Department of Cardiopulmonary Sciences, Northeastern University, Boston, MA 02115-5000, USA.

出版信息

Clin Interv Aging. 2011;6:47-52. doi: 10.2147/CIA.S15164. Epub 2011 Jan 27.

DOI:10.2147/CIA.S15164
PMID:21472091
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3066252/
Abstract

OBJECTIVE

To describe a practical method for family practitioners to stage chronic obstructive pulmonary disease (COPD) by the use of office spirometry.

METHODS

This is a review of the lessons learned from evaluations of the use of office spirometry in the primary care setting to identify best practices using the most recent published evaluations of office spirometry and the analysis of preliminary data from a recent spirometry mass screening project. A mass screening study by the American Association for Respiratory Care and the COPD Foundation was used to identify the most effective way for general practitioners to implement office spirometry in order to stage COPD.

RESULTS

A simple three-step method is described to identify people with a high pre-test probability in an attempt to detect moderate to severe COPD: COPD questionnaire, measurement of peak expiratory flow, and office spirometry. Clinical practice guidelines exist for office spirometry basics for safety, use of electronic peak flow devices, and portable spirometers.

CONCLUSION

Spirometry can be undertaken in primary care offices with acceptable levels of technical expertise. Using office spirometry, primary care physicians can diagnose the presence and severity of COPD. Spirometry can guide therapies for COPD and predict outcomes when used in general practice.

摘要

目的

描述一种家庭医生通过使用办公式肺量计来对慢性阻塞性肺疾病(COPD)进行分期的实用方法。

方法

这是对在初级保健环境中使用办公式肺量计的评估中所获得经验的回顾,使用了最近发表的关于办公式肺量计的评估和对近期大规模肺量筛查项目的初步数据分析,以确定使用办公式肺量计的最佳实践。美国呼吸护理协会和 COPD 基金会的一项大规模筛查研究用于确定普通医生实施办公式肺量计以对 COPD 进行分期的最有效方法。

结果

描述了一种简单的三步方法,以识别具有高术前概率的人群,试图检测中重度 COPD:COPD 问卷、呼气峰流速测量和办公式肺量计。存在针对办公式肺量计基本原理的临床实践指南,包括安全性、电子峰流速仪和便携式肺量计的使用。

结论

办公式肺量计可在初级保健办公室进行,且具有可接受的技术专业水平。使用办公式肺量计,初级保健医生可以诊断 COPD 的存在和严重程度。当在一般实践中使用时,肺量计可以指导 COPD 的治疗并预测结局。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e9a/3066252/6097b713bb34/cia-6-047f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e9a/3066252/6097b713bb34/cia-6-047f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e9a/3066252/6097b713bb34/cia-6-047f1.jpg

相似文献

1
Spirometry use: detection of chronic obstructive pulmonary disease in the primary care setting.肺量测定法的应用:在初级保健环境中检测慢性阻塞性肺疾病。
Clin Interv Aging. 2011;6:47-52. doi: 10.2147/CIA.S15164. Epub 2011 Jan 27.
2
Office Spirometry in Primary Care for the Diagnosis and Management of COPD: National Lung Health Education Program Update.基层医疗中用于慢性阻塞性肺疾病诊断和管理的办公室肺量计检查:国家肺部健康教育计划更新
Respir Care. 2018 Feb;63(2):242-252. doi: 10.4187/respcare.05710.
3
Strategies for screening for chronic obstructive pulmonary disease.慢性阻塞性肺疾病的筛查策略
Respir Care. 2003 Dec;48(12):1194-201; discussion 1201-3.
4
A clinical study of COPD severity assessment by primary care physicians and their patients compared with spirometry.基层医疗医生及其患者对慢性阻塞性肺疾病严重程度评估与肺功能测定的临床研究。
Am J Med. 2015 Jun;128(6):629-37. doi: 10.1016/j.amjmed.2014.12.018. Epub 2015 Jan 13.
5
Diagnosis and management of chronic obstructive pulmonary disease (COPD) in a primary care clinic.在基层医疗机构中对慢性阻塞性肺疾病(COPD)进行诊断和管理。
COPD. 2009 Dec;6(6):446-51. doi: 10.3109/15412550903341455.
6
Primary care spirometry.基层医疗中的肺功能测定
Eur Respir J. 2008 Jan;31(1):197-203. doi: 10.1183/09031936.00066607.
7
Spirometry can be done in family physicians' offices and alters clinical decisions in management of asthma and COPD.肺活量测定可在家庭医生诊所进行,并且会改变哮喘和慢性阻塞性肺疾病管理中的临床决策。
Chest. 2007 Oct;132(4):1162-8. doi: 10.1378/chest.06-2722. Epub 2007 Jun 5.
8
Targeted case finding for chronic obstructive pulmonary disease versus routine practice in primary care (TargetCOPD): a cluster-randomised controlled trial.慢性阻塞性肺疾病的目标性筛查与初级保健中的常规实践(TargetCOPD):一项集群随机对照试验。
Lancet Respir Med. 2016 Sep;4(9):720-730. doi: 10.1016/S2213-2600(16)30149-7. Epub 2016 Jul 19.
9
Discriminative Accuracy of the CAPTURE Tool for Identifying Chronic Obstructive Pulmonary Disease in US Primary Care Settings.用于识别美国初级保健环境中慢性阻塞性肺疾病的 CAPTURE 工具的判别准确性。
JAMA. 2023 Feb 14;329(6):490-501. doi: 10.1001/jama.2023.0128.
10
Pilot program on distance training in spirometry testing - the technology feasibility study.肺活量测定测试远程培训试点项目——技术可行性研究
Pneumonol Alergol Pol. 2015;83(6):431-5. doi: 10.5603/PiAP.2015.0071.

引用本文的文献

1
X-ray velocimetry in dynamic imaging: a systematic overview of approaches.动态成像中的X射线测速法:方法的系统综述
Pol J Radiol. 2025 Jun 16;90:e307-e315. doi: 10.5114/pjr/202948. eCollection 2025.
2
Evaluation of Salivary Biomarkers and Spirometry for Diagnosing COPD in Non-Smokers and Smokers of Polish Origin.唾液生物标志物和肺活量测定法在诊断波兰裔非吸烟者和吸烟者慢性阻塞性肺疾病中的应用评估
Biomedicines. 2024 May 29;12(6):1206. doi: 10.3390/biomedicines12061206.
3
Chronic Obstructive Pulmonary Disease Overdiagnosis and Overtreatment: A Meta-Analysis.

本文引用的文献

1
Quality of spirometry in primary care for case finding of airway obstruction in smokers.基层医疗保健中用于发现吸烟者气道阻塞的肺功能检测质量。
Respiration. 2010;79(6):469-74. doi: 10.1159/000243162. Epub 2009 Sep 26.
2
Prevalence of COPD among symptomatic patients in a primary care setting.基层医疗环境中有症状患者的慢性阻塞性肺疾病患病率。
Curr Med Res Opin. 2009 Nov;25(11):2671-7. doi: 10.1185/03007990903241350.
3
Tobacco treatment and prevention: what works and why.烟草治疗与预防:哪些方法有效及原因
慢性阻塞性肺疾病的过度诊断与过度治疗:一项荟萃分析
J Clin Med. 2023 Nov 8;12(22):6978. doi: 10.3390/jcm12226978.
4
Prediction of Pulmonary Function Parameters Based on a Combination Algorithm.基于组合算法的肺功能参数预测
Bioengineering (Basel). 2022 Mar 25;9(4):136. doi: 10.3390/bioengineering9040136.
5
Does Low FEV1 in Addition to Fixed Ratio and/or Lower Limit of Normal of FEV1/FVC Improve Prediction of Mortality in COPD? The NHANES-III-linked-mortality Cohort.低 FEV1 除固定比值和/或 FEV1/FVC 正常下限之外是否能改善 COPD 患者死亡率的预测?NHANES-III 相关死亡率队列研究。
J Natl Med Assoc. 2019 Feb;111(1):94-100. doi: 10.1016/j.jnma.2018.06.006. Epub 2018 Jul 29.
6
Low-Power Wearable Systems for Continuous Monitoring of Environment and Health for Chronic Respiratory Disease.用于慢性呼吸道疾病环境与健康连续监测的低功耗可穿戴系统
IEEE J Biomed Health Inform. 2016 Sep;20(5):1251-1264. doi: 10.1109/JBHI.2016.2573286. Epub 2016 May 26.
7
Prevalence of Airflow Obstruction in U.S. Adults Aged 40-79 Years: NHANES Data 1988-1994 and 2007-2010.美国40 - 79岁成年人气流阻塞的患病率:1988 - 1994年和2007 - 2010年美国国家健康与营养检查调查(NHANES)数据
COPD. 2015 Aug;12(4):355-65. doi: 10.3109/15412555.2014.948998.
8
Estimating the U.S. prevalence of chronic obstructive pulmonary disease using pre- and post-bronchodilator spirometry: the National Health and Nutrition Examination Survey (NHANES) 2007-2010.使用支气管扩张剂前后的肺量测定法估计美国慢性阻塞性肺疾病的流行率:国家健康和营养调查(NHANES)2007-2010。
Respir Res. 2013 Oct 9;14(1):103. doi: 10.1186/1465-9921-14-103.
Respir Care. 2009 Aug;54(8):1082-90.
4
A stepwise approach to management of stable COPD with inhaled pharmacotherapy: a review.吸入药物治疗稳定期慢性阻塞性肺疾病的逐步管理方法:综述
Respir Care. 2009 Aug;54(8):1058-81.
5
Spirometry for the diagnosis and management of chronic obstructive pulmonary disease.用于慢性阻塞性肺疾病诊断和管理的肺量计检查
Respir Care. 2009 Aug;54(8):1050-7.
6
The 2007 GOLD Guidelines: a comprehensive care framework.《2007年慢性阻塞性肺疾病全球倡议指南》:一个全面的护理框架。
Respir Care. 2009 Aug;54(8):1040-9.
7
Validation of the clinical COPD Questionnaire (CCQ) in primary care.基层医疗中慢性阻塞性肺疾病临床问卷(CCQ)的验证
Health Qual Life Outcomes. 2009 Mar 25;7:26. doi: 10.1186/1477-7525-7-26.
8
Smoking cessation in chronic obstructive pulmonary disease.戒烟治疗慢性阻塞性肺疾病。
Respir Med. 2009 Jul;103(7):963-74. doi: 10.1016/j.rmed.2009.02.013. Epub 2009 Mar 14.
9
Evaluation of acute bronchodilator reversibility in patients with symptoms of GOLD stage I COPD.对全球慢性阻塞性肺疾病倡议(GOLD)I 期慢性阻塞性肺疾病(COPD)症状患者急性支气管扩张剂可逆性的评估。
Thorax. 2009 Mar;64(3):216-23. doi: 10.1136/thx.2008.103598. Epub 2008 Dec 3.
10
Effect of pharmacotherapy on rate of decline of lung function in chronic obstructive pulmonary disease: results from the TORCH study.药物治疗对慢性阻塞性肺疾病肺功能下降速率的影响:TORCH研究结果
Am J Respir Crit Care Med. 2008 Aug 15;178(4):332-8. doi: 10.1164/rccm.200712-1869OC. Epub 2008 May 29.